Rankings
▼
Calendar
PRCT Q2 2024 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena
PRCT
PROCEPT BioRobotics Corporation
$1B
Q2 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$53M
+61.2% YoY
Gross Profit
$31M
59.0% margin
Operating Income
-$27M
-50.3% margin
Net Income
-$26M
-48.0% margin
EPS (Diluted)
$-0.50
QoQ Revenue Growth
+19.8%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$17M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$374M
Total Liabilities
$123M
Stockholders' Equity
$252M
Cash & Equivalents
$214M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$53M
$33M
+61.2%
Gross Profit
$31M
$18M
+70.8%
Operating Income
-$27M
-$26M
-4.7%
Net Income
-$26M
-$25M
-1.3%
Geographic Segments
UNITED STATES
$48M
89%
Outside the United States
$6M
11%
← FY 2024
All Quarters
Q3 2024 →